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Abstract Progressive human immunodeficiency virus
(HIV)-1 infection and virus-induced neuroinflammatory
responses effectuate monocyte-macrophage transmigration
across the blood–brain barrier (BBB). A key factor in
mediating these events is monocyte chemotactic protein-1
(MCP-1). Upregulated glial-derived MCP-1 in HIV-1-
infected brain tissues generates a gradient for monocyte
recruitment into the nervous system. We posit that the inter-
relationships between MCP-1, voltage-gated ion channels,
cell shape and volume, and cell mobility underlie monocyte
transmigration across the BBB. In this regard, MCP-1
serves both as a chemoattractant and an inducer of
monocyte-macrophage ion flux affecting cell shape and
mobility. To address this hypothesis, MCP-1-treated bone
marrow-derived macrophages (BMM) were analyzed for
gene and protein expression, electrophysiology, and capac-
ity to migrate across a laboratory constructed BBB. MCP-1
enhanced K+ channel gene (KCNA3) and channel protein
expression. Electrophysiological studies revealed that
MCP-1 increased outward K+ currents in a dose-dependent
manner. In vitro studies demonstrated that MCP-1 increased
BMM migration across an artificial BBB, and the MCP-1-
induced BMM migration was blocked by tetraethylammo-
nium, a voltage-gated K+ channel blocker. Together these
data demonstrated that MCP-1 affects macrophage migratory
movement through regulation of voltage-gated K+ channels
and, as such, provides a novel therapeutic strategy for
neuroAIDS.
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Introduction
Chemokines are structurally defined small proteins that serve
as leukocyte chemoattractants for a variety of inflammatory
diseases including those of the central nervous system (CNS;
Rebenko-Moll et al. 2006; Callewaere et al. 2007; Mines et al.
2007). They affect a variety of divergent biological activities
that include cell migration to sites of disease and inflamma-
tion, leukocyte activation, leukocyte secretions, and microbial
activities (infection and cellular clearance; Callahan and
Ransohoff 2004; Banisadr et al. 2005; Rebenko-Moll et al.
2006; Ubogu et al. 2006; Li and Ransohoff 2008). One of the
most investigated and disease-associated chemokine is
monocyte chemoattractant protein-1 (MCP-1), which plays a
pivotal role in the recruitment of mononuclear phagocytes
(MP; blood-borne monocytes, dendritic cells, and macro-
phages) to sites of inflammation and malignancies (de la Rosa
et al. 2003; Garlet et al. 2003; Yao et al. 2006; Buhling et al.
2007; Tsai et al. 2008). The mechanism of such recruitment is
well studied. Indeed, migration of monocytes across the
vascular endothelium is linked to cells tethering to the
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endothelium, rolling along the vascular surface, firmly
adhering to the endothelium, and finally diapedesis between
tight morphologically structured endothelial cells, processes
that are explicatively linked to both chemokine and adhesion
molecule expression (Strell et al. 2007; Vestweber 2007; Crane
2008). After penetration of the endothelial basement mem-
brane, monocytes migrate through the extracellular matrix of
the tissues where they differentiate into tissue macrophages
and migrate to sites of inflammation (Whatling et al. 2004;
Fulcher et al. 2006; Reinhart et al. 2006; Cesar et al. 2008).
Monocyte migration is mediated through selectins and their
ligands or integrins interacting with endothelial vascular cell
adhesion molecule 1 (VCAM-1). VCAM-1 is expressed at
low levels on the endothelium and upregulated after immune
activation (Lane et al. 1996; Nottet et al. 1996). On the apical
endothelial surface, the chemokines MCP-1 and macrophage
inflammatory proteins-alpha/beta, (MIP-1alpha/beta) activate
beta(2) integrins to facilitate firm adhesion (Biernacki et al.
2004; Maslin et al. 2005). Diapedesis by monocytes occurs
through interaction between integrins on both the monocyte
and the endothelial cells, followed by homophilic adhesion
(Muller and Randolph 1999; Schenkel et al. 2002; Mamdouh
et al. 2008). The intracellular mechanisms for these processes
are linked to activation by tyrosine phosphorylation of cellular
proteins and phosphorylation of the non-receptor tyrosine
kinases Lyn, JAK2, the cytoskeletal binding protein paxillin,
and downstream transcription factors STAT3 and STAT5
(Muller et al. 2005). In this manner, MCP-1 induces TNF-α
and IL-1 production and promotes macrophage activation
(Biswas and Sodhi 2002).
Monocyte trafficking is of special interest in studies of
the neuropathogenesis of HIV infection, including estab-
lishment of viral reservoirs and the development of HIV-
associated neurocognitive disorders (HAND; Venneti et al.
2004; Williams et al. 2005; Berman et al. 2006). However,
the process of monocyte migration across the vascular
endothelium and changes in migration that occur during
HIV infection are incompletely understood. We theorized
that since MCP-1 can elicit activation responses for macro-
phages, the actual influence of the chemokine on monocyte-
macrophage physiology would be profound. In this manner,
a linkage between MCP-1 and potassium (K+) channel
expression would be apparent. Blockers of these channels
altered the organization and structure of the cytoskeletal
proteins actin, tubulin, and vimentin; adherence-mediated
macrophage activation; and maintenance of cytoskeletal
integrity and cell shape. Such cytoskeletal changes were
associated with cell morphology changes. We now demon-
strate that MCP-1 activation of monocytes leads to
morphological alterations that are directly linked to K+
channels. Chemokine-mediated responses lead to a dosage
escalation of channel responses and to alterations in size,
shape, volume, and ingress across an artificial BBB. The
observations, taken together, provide unique insights into
how MCP-1 can affect movement of monocytes across
barriers and most notably into the CNS.
Materials and methods
BMM cultivation Bone marrow cells were obtained from
femurs of 6-week-old C57/BL6 or BALB/c male mice
(purchased from Jackson Laboratory, Bar Harbor, MN).
Cells were cultured in Teflon flasks at 2×106 cells/ml in
complete Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum, 2 mM L-
glutamine, and 1% penicillin/streptomycin) in the presence
of mouse macrophage colony stimulating factor (M-CSF)
2 µg/ml (a gift from Wyeth, Cambridge, MA). After 5–
6 days in culture, BMM were determined to be >95%
CD11b+ by flow cytometry and utilized thereafter.
Whole-cell patch clamp recording BMM were plated onto
sterile glass coverslips at a density of 0.5×106 cells/slip.
Whole-cell patch-clamp recordings were made using an
Axopatch 200B amplifier (Molecular Devices, Sunnyvale,
CA) interfaced with a Digidata 1322A digitizer (Molecular
Devices) and controlled with pClamp Version 8.1 software
(Molecular Devices). Whole-cell currents were filtered at
1 kHz, digitized at 10 kHz, and stored on a computer hard
disk. Patch pipettes were fabricated from borosilicate glass
capillaries using a Sutter P97 microelectrode puller, with tip
resistances of 4–8 MΩ when filled with pipette solution
containing (in mM) 130 K+ gluconate, 10 EGTA, 1 CaCl2,
1 MgCl2, and 10 HEPES (pH 7.2, 280 mOsm). The bathing
solution contained (in mM) 135 Na + gluconate, 5 KCl, 1
CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose (pH 7.4,
290 mOsm). Values of access resistance ranging from 8 to
18 MΩ were compensated at 60–70% in most cells. Whole-
cell voltage-dependent outward K+ currents were recorded in
response to a series of voltage steps from −160 to +100 mV in
20 mV increments, starting from a holding potential of
−60 mV. The steady-state current magnitudes were measured
and normalized as a percentage of the magnitudes generated
by a voltage step from −60 mV to +100 mV in control
(perfused with normal bath solution). For statistical analyses,
paired Student’s t tests were used with statistical significance
at p<0.05.
Isolation and culture of primary human monocytes Human
monocytes were obtained from HIV-1, HIV-2, and hepatitis
B seronegative adults by leukophoresis and purified by
countercurrent centrifugal elutriation. Monocytes were
cultured in DMEM (Sigma, St. Louis) supplemented with
10% heat-inactivated human serum, 2 mM L-glutamine,
gentamicin (50 μg/ml), and 2 μg/ml M-CSF. After 7 days
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in culture, monocytes differentiated into macrophages and
the monocyte-derived macrophages (MDM) were infected
with HIV-1ADA at a multiplicity of infection of 0.01 for
24 h before being injected into the brain of severe
combined immunodeficient (SCID) mice.
SCID mouse model of HIVE SCID mice (male C.B-17,
4 weeks old) were purchased from the Charles River
Laboratories (Wilmington, MA). Each animal was inocu-
lated in the basal ganglia (caudate and putamen) with 5 μl
of either an HIV-1ADA-infected or uninfected human MDM
suspension containing 3×105 cells. All animal procedures
were approved by the Institutional Animal Care and Use
Committee of University of Nebraska Medical Center.
BMM tracking by CT/SPECT BMM were labeled with
111indium (111In) oxyquinoline (Indium oxine, GE Healthcare,
Arlington Heights, IL) at a dose of 600 μCi per 30×106
cells in 1 ml RPMI 1640 supplemented with 10 mM
HEPES for 45 min at 37°C. Cells were washed and
resuspended in Hank’s buffered salt solution. Labeling
efficiency was determined by γ-scintillation spectrometry
(Packard Instrument Co., Meriden, CT) and was >75% of
total input isotope. Each recipient mouse received 111In-
labeled BMM by i.v. injection. Replicate groups of animals
were simultaneously injected intraperitoneally (i.p.) with
4-aminopyridine daily (4-AP, 1 mg/kg) dissolved in
phosphate-buffered saline (PBS). Mice were anesthetized
with 0.5–1% isoflurane delivered in a 2:1 mixture of nitrous
oxide and oxygen. Image acquisition was accomplished by
a computed tomography/single photon emission computed
tomography system (CT/SPECT; FLEX Triumph, Gamma
Medica-Ideas, Northridge, CA). CT images were acquired
by an X-ray detector, while SPECT images were acquired
with a γ-scintillation camera detector fitted with 5 pinhole
collimator. Co-registration of anatomical CT images and
functional SPECT was performed by 3D image visualiza-
tion and analysis software VIVID Gamma Medica-Ideas).
The specific tissue and region of interest (ROI) of active
viral encephalitis were defined and relative radioactivity for
each area determined.
RNA extraction and real-time RT-PCR Total RNA was
isolated from cells using TRIzol Reagent (Invitrogen,
Carlsbad, CA) and was purified by RNeasy Mini Kit
(Qiagen, Inc., Valencia, CA). Real-time reverse tran-
scription polymerase chain reaction (RT-PCR) for mouse
KCNA3, KCND1, and KCNN4 was performed using
the one-step quantitative TaqMan real-time RT-PCR
system (Applied Biosystems, Inc., Foster City, CA).
Gene expression levels were normalized to glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) as internal
control.
Western blots Total proteins were prepared from BMM
treated with MCP-1 or lipopolysaccharide (LPS) and equiv-
alent amounts were electrophoretically separated on 4–15%
sodium dodecyl sulfate polyacrylamide gel then transferred to
Trans-Blot nitrocellulose membrane (BioRad, Hercules, CA).
The membranes were probed with rabbit polyclonal anti-
bodies to Kv1.3 and Kv1.5 (Almonade Lab, Israel) and
images visualized with a chemoilluminescent horseradish
peroxidase substrate kit (Pierce Biotechnology, Rockford, IL).
Immunohistochemistry BMM were fixed in 3.7% formalde-
hyde solution for 10 min at room temperature, permeabilized
in 0.1% Triton X-100 for 3 to 5 min. Nonspecific binding on
BMM was blocked with 1% bovine serum albumin in
phosphate-buffered saline for 30 min and stained for actin
expression with rhodamine phalloidin. All samples were
viewed on a confocal microscope.
Chemotaxis assay BMM were labeled with 2.5 μM 5-
chloromethylfluorescein diacetate (CMFDA) (Invitrogen)
in serum-free DMEM at 37°C for 15 min, washed, and
adjusted to 3×106 cells/ml in complete DMEM. Tetraethy-
lammonium chloride (TEA) was used to inhibit K+
channels. The CMFDA-labeled cells were loaded into
chemotaxis µ-slides (ibidi, GmbH, Munich, Germany) in
10 μl per chamber and incubated at 37°C for 35 min to
allow cell attachment. Fresh or conditioned media (CM)
was loaded into adjacent reservoirs of central channel, and
the cells were imaged continuously for 2 h using a Nikon
swept-field laser confocal microscope (Nikon Instruments,
New York, NY). Images were analyzed using different
plugins interfaced with ImageJ 1.38X software (Rasband,
W.S., ImageJ, US National Institutes of Health, Bethesda,
MD, USA, http://rsb.info.nih.gov/ij/, 1997–2007). Migration
coordination data for each observed cell was acquired with
the Manual Tracking plugin (Fabrice Cordelières, Institut
Curie, Orsay, France). Chemotaxis plots and migration
velocities of each cell were determined with the Chemotaxis
and Migration Tool (ibidi).
Transendothelial migration Transendothelial migration of
BMM assay was measured using a quantitative fluores-
cence-based assay. First, mouse brain endothelial cells b.
END3 (ATCC, Manassas, VA) were plated on rat-tail
collagen type-I-coated FluoroBlok tinted tissue culture
inserts (with 3-μm pores; BD Biosciences, San Diego,
CA) at a density of 1.5×104 cells/insert (Ramirez et al.
2008; Yamamoto et al. 2008). Thereafter, endothelial cells
and BMM were treated with TEA for 30 min, and
recombinant mouse MCP-1 (CCL2/MCP-1, 30 ng/ml;
R&D Systems, Minneapolis, MN) was introduced into the
lower chamber to create a chemokine gradient similar to
that present in neuroinflammatory disorders. Labeled BMM
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(8×104 cells/insert loaded with calcein-AM at 5 μM/1×106
cells for 45 min) were placed in the upper chamber, and
migration was allowed to continue up to 4 h at 37°C.
Migration was monitored by measuring the relative fluo-
rescence of the labeled BMM found in the lower chamber
by fluorescence spectrometry (Molecular Devices). The
numbers of migrated BMM were derived from a standard
curve of the relative fluorescence as a function of known
numbers of labeled BMM.
Results
MCP-1 increased outward K+ currents in BMM
Voltage-gated K+ channels (Kv) play a key role in cell
volume regulation and as such, cell movement. Under
whole-cell voltage clamp recording, outward currents were
evoked on BMM by voltage steps (Fig. 1A). These voltage
sensitive outward currents were blocked by TEA, a voltage-
gated K+ channel blocker (Fig. 1B), suggesting the
expression of Kv channels in BMM. Because MCP-1 is
expressed in inflamed tissues serving as a pivotal chemo-
attractant for cell migration and Kv channels are involved
in controlling macrophage migration and proliferation
(Gallin 1991), we investigated its influence on BMM Kv
channels. As shown in Fig. 1A, bath perfusion of MCP-1
increased the outward K+ currents induced by a voltage
step from −60 to +100 mV with the holding potential of
−60 mV in a dose-dependent manner. The average
magnitude of steady-state outward K+ currents before
application of MCP-1 was 100.0±2.6% of control (M ±
SD, n=9). In contrast, bath application of MCP-1 at
concentrations of 2, 20, and 200 ng/ml increased the
steady-state K+ currents to 164.1±1.75%, 191.7±4.2%,
and 344.0±24.0% of control, respectively (n=9, Fig. 1B).
After washout of MCP-1, the outward K+ currents returned to
control levels (before application of MCP-1), with an average
magnitude of 106.7±6.4% of control (n=9). Based on these
observations, we next examined whether the Kv channel
blocker, TEA, could block K+ currents induced by MCP-1.
In another set of BMM, bath application of MCP-1 (20 ng/
ml) alone increased the steady-state outward currents to an
average of 167.3±18.8% of control (n=5, Fig. 2). However,
when MCP-1 was co-applied with TEA (20 mM), the
average steady-state outward K+ currents decreased (p<
0.05) by 83.5±15.6% of control (n=5, Fig. 2), suggesting
that MCP-1-mediated enhancement of outward K+ current is
sensitive to Kv channel blockers. After washout of MCP-1
and TEA, the outward K+ currents returned to control levels,
with an average of 96.6±9.7% of control (Fig. 2, n=4).
MCP-1 regulates K+ channel gene expression
To determine the responsiveness of K+ channel to MCP-1,
we investigated the messenger RNA (mRNA) abundance
and protein expression level of genes related to K+ channel.
As shown in Fig. 3, we measured KCND1 (Kv4.1),
KCNA3 (Kv1.3), and KCNN4 (KCa3.1) mRNA levels of
BMM after treatment with MCP-1 and LPS. The results
showed that KCNA3 gene expression is significantly
increased 30 and 60 min after treatment with MCP-1
Fig. 1 MCP-1 enhanced out-
ward K+ currents in C57BL/6
mouse bone-marrow-derived
macrophages (BMM). A Repre-
sentative recordings from BMM
before (control), during, and
after (wash) bath perfusion with
MCP-1 were assessed at differ-
ent concentrations of 2, 20, and
200 ng/ml. Note that MCP-1
enhanced outward K+ currents
in a concentration-dependent
manner. B Concentration-
dependent effects of MCP-1
were assessed on the steady-
state outward K+ currents
induced by a voltage step from
−60 mV (holding potential) to
+100 mV. Bath application of
MCP-1 significantly increased
K+ currents, as compared with
control (n=9). C The voltage
jump protocol employed in this
study is shown. *p<0.05,
**p<0.01
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(Fig. 3C, p<0.01). Considering that Kv1.3 and Kv1.5
account for most of the voltage-gated K+ currents
expressed by BMM, we tested the protein expression of
Kv1.3 and Kv1.5. After treatment with MCP-1 for 30 and
60 min, Kv1.3 and Kv1.5 protein expression was readily
increased by BMM (Fig. 3D). The results suggested that
some K+ channel genes are regulated by MCP-1.
MCP-1 affects BMM F-actin reorganization
F-actin reorganization is essential for cell morphogenesis
and migration. Based on morphology and F-actin distribu-
tion within BMM, macrophages can be categorized into
four groups showing: (1) ramified macrophages with more
than two protrusions, (2) elongated cells with two protru-
sions, (3) round cells with no protrusions, and (4) migratory
cells with one or more rich lamellae and a tail (polarized F-
actin). Migratory morphology was present in 25±2.9% of
unstimulated control group; whereas, after stimulation with
20 ng/ml MCP-1 for 1 h, 48.56±1.7% of the cells exhibited
a migratory morphology (p<0.05, Fig. 4A,B).
MCP-1 facilitated BMM migration and is blocked by K+
channel antagonists
To investigate how MCP-1 influences BMM migration, we
monitored the mobility of CMFDA-labeled BMM in
chemotaxis chambers by laser confocal microscopy live
imaging (Fig. 5A–C). Minimal BMM migration was
observed in fresh media (Fig. 5A). However, levels of
BMM migration significantly increased when MCP-1 was
introduced to the migratory system (Fig. 5B). This level of
BMM migration was attenuated by TEA, a non-specific
voltage-gated K+ channel blocker (Fig. 5C). These results
were consistent with the measured mean migration speed.
In control media, BMM migrated at 138.5±29.9 nm/min
(mean ± SEM), which increased to 368.6±37.5 nm/min in
MCP-1-conditioned media (Fig. 5D). However, after co-
culture with TEA and MCP-1, BMM migration speed was
reduced to 143.0±18.6 nm/min, levels comparable to those
obtained in control media. Together, these observations
demonstrated that MCP-1 significantly affects BMM
mobility by activating K+ channels.
Fig. 2 Blockade of MCP-1-induced enhancement of outward K+
current by TEA. A Whole-cell outward K+ currents were recorded
from a bone-marrow-derived macrophage before (control), during bath
application of MCP-1 (MCP-1, 20 ng/ml), TEA+MCP-1 (20 ng/ml of
each) (TEA+MCP-1), and washout period (washout). Note that the
blockade of MCP-1-induced increase of outward K+ currents was
significantly blocked by TEA (20 mM). B I–V curves were constructed
from the results shown in A. C The steady-state K+ current induced by
a voltage step from −60 to +100 mV was significantly increased by
MCP-1 (p<0.05, n=5). The MCP-1-induced increase of outward K+
currents was significantly blocked by bath application of TEA (p<
0.01, n=5). Voltage jump protocol employed was the same as shown
in Fig. 1C. Asterisks Compared with control group; number sign
compared with MCP-1 alone group
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K+ channels regulate BMM BBB transmigration
Since MCP-1 increased BMM mobility and TEA attenuated
mobility, we determined the biological importance of these
observations by assessing whether MCP-1-induced BMM
migration across an in vitro BBB was affected by a Kv
channel antagonist. We used a mouse brain endothelial cell to
construct the in vitro barrier system and evaluated BMM
Fig. 4 MCP-1 increased the
migratory morphology of
BMM. A BMM cells were
stimulated with LPS or MCP-1
for 60 min, fixed with formal-
dehyde, and stained with rhoda-
mine phalloidin. Examples of
round, migratory, ramified, and
elongated BMM cells are indi-
cated by blue, yellow, green, and
white arrows, respectively. B
BMM numbers were counted
from slides based on different
morphologies: round, migratory,
ramified, and elongated for
BMM cells treated with MCP-1
(gray bar), LPS (black bar), or
media alone (control) (white
bar). BMM numbers were
normalized to percent of total
number of BMM. *P<0.01
compared with control
Fig. 3 MCP-1 altered K+ channel gene and protein expression in
mouse BMM cells. BMM were stimulated with LPS or MCP-1 and
mRNA was extracted at 0, 30, and 60 min after stimulation,
respectively. Abundance of mRNAs for individual samples was
quantified using quantitative RT-PCR and normalized to GAPDH.
Data were presented as fold-increase of specific mRNA species
encoding for A KCND1, B KCNA3, and C KCNN4. D BMM cells
were stimulated with LPS or MCP-1. Protein was extracted at 0, 30,
and 60 min after stimulation, respectively, for Western blot analysis.
Western blot analysis results show that MCP-1-induced increases in
Kv1.5 and Kv1.3 protein expression
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trans-endothelial migration in the absence or presence of
MCP-1 and/or TEA. BMM cultured with MCP-1 increased
BMM migration across the endothelium compared to migra-
tion in the absence of MCP-1 (Fig. 6A). In contrast, the ability
of the BMM to migrate across the endothelium in the presence
of TEA was significantly decreased. Similar results were
obtained when both cell types were exposed to TEA (Fig. 6B).
Taken together, these results suggested that K+ channels play
a central role in MCP-1-induced BMM migration.
CT/SPECT analysis of 111In-labeled BMM transmigration
in peripheral tissues
To assess real-time migration of macrophages, 1×107 111In-
labeled BMM were adoptively transferred to normal
recipients or recipients treated i.p. with 4-AP, and migration
was assessed by CT/SPECT at 2, 24, 48, and 72 h following
adoptive transfer. At 2 h post-transfer time point, radio-
labeled BMM were detected in lung tissue with reduced
signal in spleen and liver (Fig. 7A); however, by 24 h post-
transfer, the predominant signal was localized to spleen and
liver. To quantify labeled BMM within each tissue, regions
of interest were electronically mapped and total radioactiv-
ity counts determined. Relative number of counts/tissue
volume confirmed that BMM levels in lungs were higher
by 2 h then decreased quickly thereafter (Fig. 7B). Labeled
BMM levels in liver and spleen were lower at the first 2 h;
however, by 24 h, higher levels were observed in liver and
spleen and diminished thereafter, indicating that most BMM
migrated to liver and spleen (Fig. 7C,D). Comparable levels
of labeled BMM migration in animals were observed
regardless of treatment with or without AP-4 K+ channel
(p>0.05). These results suggest that K+ channel blocker had
no effect on BMM migration into peripheral tissues under
non-inflammatory conditions.
CT/SPECT analysis of 111In-labeled BMM transmigration
into brains of HIVE mice
We next assessed the effects of K+ channel blockade on
BMM migration to the brain and across the BBB under
inflammatory conditions exhibited in a murine model of
Fig. 5 BMM mobility increased after treated with MCP-1 and blocked
by TEA. Chemotaxis Assay 2-Reservoir μ-slides (ibidi, LLC) was
utilized to generate MCP-1 gradient and monitor BMM mobility by
confocal microscopy live imaging. BMM migration over a defined
area was determined for A both reservoirs filled with fresh media to
generate a control environment; B MCP-1 loaded one reservoir with
media and BMM in the other, and C MCP-1 applied to one reservoir,
BMM introduced into the other, and TEA (20 mM) applied to both
reservoirs. BMM migration was assessed by live imaging over 2 h and
analyzed by Image J software with chemotaxis tools plugins. D BMM
migration in the presence of media alone, MCP-1, and MCP-1 in the
presence of TEA was evaluated as a function of speed. *p<0.05
compared to MCP-1-treated BMM
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HIVE. Here, HIV-1ADA-infected MDMs were injected
intracranially by stereotactic measures within the caudate
and putamen. After 3 days, 1×107 111In-labeled BMM were
adoptively transferred i.v. to control, HIVE, and HIVE mice
treated with AP-4 K+ blocker. BMM transmigration into
the brain and the brain subregion with active encephalitis
were tracked by CT/SPECT at 2, 24, and 48 h post-transfer.
Whole-brain and injection site were electronically bitmap-
ped in reconstructed 3D images, and relative radioactive
levels were determined for each recipient (Fig. 8A). Counts
within the whole brain (Fig. 8B) and ROI area (Fig. 8C) are
shown. Quantitative analyses of those bitmapped tissues
demonstrated that radioactive counts of BMM from HIVE
mice treated with AP-4 K+ blocker were significantly
diminished within whole brains by 24 h post-transfer
compared to control or HIVE mice (Fig. 8B). Upon closer
examination of the area containing the injection site and
thus the focal HIVE, relative counts from K+ blocker-
treated animals significantly diminished by 2 h and times
thereafter when compared to the HIVE animals (Fig. 8C).
These results suggest that K+ channels clearly affect the
migration of BMM to the brain within the context of HIVE
inflammatory conditions.
Discussion
Several different subtypes of Kv channels are expressed in
human and mouse monocytes and macrophages including,
but not limited to Kv1.3, Kv1.5 (Gallin 1991; Mackenzie
et al. 2003; Vicente et al. 2003). These channels play an
important role in controlling macrophage functions such as
proliferation, activation, migration, and cytokine production
(Gallin 1991; DeCoursey et al. 1996; Qiu et al. 2002).
Studies have shown that Kv channels in macrophages can
be regulated by many factors including proinflammatory
cytokines. In the present study, we have demonstrated that
MCP-1, a glial-derived cytokine, enhanced outward K+
currents and macrophage transmigration via regulation of
Kv channel expression and channel activity. Our results
herein fully support works by others demonstrating the
expression of Kv channels in monocytes and macrophages
(Mackenzie et al. 2003; Vicente et al. 2005, 2006; Irvine et
al. 2007; Villalonga et al. 2007). Voltage-gated K+ channels
including Kv1.3 channels are operative in blood-borne
macrophages, tissue macrophages, and microglia, and are
prominently induced concomitant with M-CSF-dependent
proliferation.
It is well known that differential channel regulation
affects intracellular signals and is linked to macrophage
activation and differentiation as well as to immune,
morphological, and migratory responses of the cells
(DeCoursey et al. 1996; Mackenzie et al. 2003; Fordyce
et al. 2005; Rus et al. 2005; Vicente et al. 2005; Irvine et al.
2007). LPS activation, for example, differentially regulates
channel expression, as demonstrated by the induction of
Kv1.3 channels and down-regulation of Kir2.1 channels.
This modulation is dependent on the mode of macrophage
immune responses (Gerth et al. 2005; Lei et al. 2005; Hoa
et al. 2007; Villalonga et al. 2007). In this report, we have
shown by pharmacological, mRNA, and protein analyses
that macrophage ion currents are operative through Kv1.3
and Kir2.1 channels. This provides further support for the
physiological importance of potassium channels in macro-
phage immunity. For example, it is well known that Kv1.3
channels are those principally found in macrophages and in
other blood leukocytes (Mackenzie et al. 2003; Vicente et
al. 2003; Fordyce et al. 2005; Vicente et al. 2005). For T
cells, these channels are important since they serve as a
primary regulator and affector of cell activation, as well as in
maintaining resting membrane potential and ion homeostasis
(Estes et al. 2008; Poulopoulou et al. 2008). Importantly, less
is known about the functional roles of channels in disease,
although Kv1.3 blockade has been shown to reduce
proinflammatory cytokine secretion and cell proliferation
(Irvine et al. 2007), as well as to slow cell movement. Such
findings serve as a foundation for investigations into whether
channel modulation can be utilized as a therapeutic target for
Fig. 6 Effects of MCP-1 on BMM migration across a murine BBB.
BMM migration across mouse brain endothelial cells toward MCP-1
(20 ng/ml) was evaluated after 2 h. a BMM were pretreated with TEA
for 30 min and then removed before migration. b Both BMM and
mouse brain endothelial cells were pretreated with TEA for 30 min.
Data are represented as mean ± SEM for numbers of migrated BMM.
*P<0.05 for comparisons of groups attached by indicated lines
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autoimmune disease such as multiple sclerosis as suggested
from studies showing that selective Kv1.3 channel blockers
diminish disease progression in experimental allergic en-
cephalomyelitis (Gonsette 2004; Vianna-Jorge and Suarez-
Kurtz 2004; Beeton and Chandy 2005; Panyi 2005; Rus et
al. 2005; Beraud et al. 2006).
In hippocampal microglia, Kv channel toxins affect
pathobiological responses and cell migration across tissue
barriers (Bordey and Spencer 2003; Fordyce et al. 2005;
Thomas et al. 2007). Cytokines, toll receptor activation, and
phorbol esters upregulate macrophage expression of Kv
channels. Kv channel expression has been shown to be
strongly upregulated in macrophage populations and only
recently has the functional role of these channels been
shown. First, extracellular K+ can activate T cell ß1 integrin
and mediate adhesion and cell migration (Levite et al. 2000;
Artym and Petty 2002; Davis et al. 2002). The gating of
leukocyte voltage-gated K+ channels (Kv1.3) affects phys-
iological responses, including elevated extracellular K+
levels, integrin functions, and cell volume changes since
they are linked to cell migration (Colden-Stanfield and
Scanlon 2000; Colden-Stanfield 2002). Ion channels are
known to affect macrophage function. For human macro-
phages, the major ionic currents are carried by an outwardly
rectifying K+ channel activated by adhesion onto a substrate
stretch applied to membrane patches. While K+ channels
govern properties of cell movement, chloride and K+
channels contribute to the regulation of biological responses
including nitric oxide. Indeed, nitric oxide synthase is
inhibited by channel blockers. Thus, a range of ion channels
expressed by macrophages and microglia is linked to cell
biology (Gerth et al. 2005; Lei et al. 2005; Hoa et al. 2007;
Villalonga et al. 2007).
The linkages shown in this report between MCP-1, K+
channels, and macrophage migration across the BBB are
significant in regards to the pathogenesis of HAND for a
Fig. 7 Peripheral BMM migration in non-HIVE mice is not affected
by K+ channel blockade. BMM were isolated from the femurs BALB/
C mice and grown in MCSF-containing media. After 1 week of
cultivation, 1×107 BMM cells (purity by CD11b staining of 95%)
were recovered, labeled with 111In oxine (indium), and transferred by
i.v. injections to two groups of naive mice (four animals/group). Mice
were then treated with either PBS (control) or 1 mg/kg of the K+
channel blocker, AP-4 (blocker), administered by daily i.p. injections.
a A representative animal was imaged 2 h (left panel) and 24 h (right
panel) after injection of indium-labeled BMM and CT images were
co-registered with SPECT images (Gamma Medica-Ideas Inc.).
Intensities of radioactive signals from indium-labeled BMM are
shown as pseudo-colored blue-green signals. Quantitative assessment
of labeled BMM distributions in PBS (control) and AP-4 (blocker)
treated mice were calculated for b lung, c liver, and d spleen by digital
image software (VIVID, Gamma Medica-Ideas, Inc.). Relative
radioactive counts as a function of pixel intensities were determined
and presented as the means ± SEM for four mice/group
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variety of reasons. HIV-1 transactivator protein Tat or
progeny virus released from infected macrophages signifi-
cantly increases astrocyte production and release of MCP-1
(Eugenin et al. 2005; El-Hage et al. 2006). MCP-1 is also
expressed at high levels in the brains of patients with HIV-1-
associated dementia (HAD), and MCP-1 levels within the
cerebrospinal fluid correlate with the severity of neurological
dysfunction (Sevigny et al. 2004; Maslin et al. 2005;
Sevigny et al. 2007). Such observations are mirrored in
simian immunodeficiency virus infected macaques with
pathological features of HIVE (Zink and Clements 2002;
Mankowski et al. 2004; Harrington et al. 2007). Homozy-
gosity for the MCP-1-2578G allele was linked to a 50%
reduction in the risk of HIV-1 acquisition. However,
following HIV-1 infection, this MCP-1 genotype was
associated with accelerated disease and a 4.5-fold increased
risk of acquiring HAD. The mutant MCP-1-2578G allele
yields increased transcriptional activity, protein production,
and serum MCP-1 levels concomitant with accelerated MP
tissue migration (Gonzalez et al. 2002).
To evaluate the biological significance of potassium
channel influence on BMM migration into the brain, we
investigated BMM migration in a SCID mouse model with
HIVE using CT/SPECT. HIVE was induced by i.c.
injection of HIV-1ADA-infected MDM into the caudate
and putamen of SCID mice and was characterized by robust
inflammation and the generation of an MCP-1 gradient for
BMM attraction into sites of active disease. In this work,
comparisons of BMM brain migration between uninfected
and HIVE mice that were either untreated or treated with 4-
aminopyridine (4-AP), a K+ channel blocker, showed that
Kv channel blocker had no effects on BMM distribution in
the peripheral organs but significantly reduced BMM
migration into the mouse brain. These results further
reinforce the biological importance of potassium channels
for macrophage migration and its links to MCP-1 and
inflammatory responses.
The data, taken together, build on previous works
demonstrating a link between MCP-1 induced biological
responses and specific ion channels. MCP-1 certainly has a
multifaceted role in HAND through its abilities to affect
proinflammatory properties and contribute to disease
progression and increased risk of dementia by affecting
MP ingress into the brain. The importance of the current
study rests in that these physiological responses to MCP-1
play a central role in HAND and as such opens up new
therapeutic targets for disease.
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